Biomarker of Diabetic Retinopathy — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Biomarker of Diabetic Retinopathy — Stella

Recruiting

Back to Diabetic Retinopathy trials

Trial locations(3 sites)

United States

Spring Mill Clinic, Carmel, Indiana

Eskenazi Eye Clinic, Indianapolis, Indiana

Glick Eye Institute, Indianapolis, Indiana

Key details

Sponsor

Indiana University

Enrollment target

~192 participants

Started

January 2022

Primary completion

June 2026

Age range

18 Years and older

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov